Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record for the completed cabozantinib study is now displayed instead of an access-denied page, with study details and a linked protocol and statistical analysis plan.SummaryDifference51%

- Check8 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0; the page continues to display a 403 error.SummaryDifference0.3%

- Check15 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about a transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) across NIH content.SummaryDifference1%

- Check22 days agoChange DetectedThe ClinicalTrials.gov error page displays a newer site revision identifier, changing from v3.7.1 to v3.7.2.SummaryDifference0.3%

- Check29 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden response.SummaryDifference0.3%

- Check50 days agoChange DetectedThe page now shows a 403 Forbidden error page, with a simple header and footer, replacing the expected study details. This indicates the study record is temporarily inaccessible rather than displaying its content.SummaryDifference19%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.